Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Sep;92(3):1436–1443. doi: 10.1172/JCI116720

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

N Fukuda 1, H Tanaka 1, Y Tominaga 1, M Fukagawa 1, K Kurokawa 1, Y Seino 1
PMCID: PMC288288  PMID: 8397225

Abstract

The resistance of parathyroid cells to 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) in uremic hyperparathyroidism is thought to be caused, in part, by a 1,25(OH)2D3 receptor (VDR) deficiency in the parathyroids. However, results of biochemical studies addressing VDR numbers in the parathyroids are controversial. Several studies have found VDR content to be decreased in the parathyroids of uremic patients and animals, while others have found no such decrease in the parathyroids of uremic animals. To clarify the role of VDR, we investigated VDR distribution in surgically-excised parathyroids obtained from chronic dialysis patients by immunohistochemistry. We classified the parathyroids as exhibiting nodular or diffuse hyperplasia. Our studies demonstrated a lower density of VDR in the parathyroids showing nodular hyperplasia than in those showing diffuse hyperplasia. Even in the parathyroids showing diffuse hyperplasia, nodule-forming areas were present; these areas were virtually negative for VDR staining. A significant negative correlation was found between VDR density and the weight of the parathyroids. These findings indicate that the conflicting results of biochemical studies may be caused by the heterogeneous distribution of VDR; the decreased VDR density in parathyroids may contribute to the progression of secondary hyperparathyroidism and to the proliferation of parathyroid cells that is seen in uremia.

Full text

PDF
1436

Images in this article

1437Image
on p.1437
1437Image
on p.1437
1438Image
on p.1438
1438Image
on p.1438
1439Image
on p.1439
1439Image
on p.1439
1441Image
on p.1441
1441Image
on p.1441

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akerström G., Malmaeus J., Grimelius L., Ljunghall S., Bergström R. Histological changes in parathyroid glands in subclinical and clinical renal disease. An autopsy investigation. Scand J Urol Nephrol. 1984;18(1):75–84. doi: 10.3109/00365598409182168. [DOI] [PubMed] [Google Scholar]
  2. Brown A. J., Dusso A., Lopez-Hilker S., Lewis-Finch J., Grooms P., Slatopolsky E. 1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int. 1989 Jan;35(1):19–23. doi: 10.1038/ki.1989.3. [DOI] [PubMed] [Google Scholar]
  3. Cantley L. K., Russell J., Lettieri D., Sherwood L. M. 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture. Endocrinology. 1985 Nov;117(5):2114–2119. doi: 10.1210/endo-117-5-2114. [DOI] [PubMed] [Google Scholar]
  4. Chan Y. L., McKay C., Dye E., Slatopolsky E. The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells. Calcif Tissue Int. 1986 Jan;38(1):27–32. doi: 10.1007/BF02556591. [DOI] [PubMed] [Google Scholar]
  5. Delmez J. A., Tindira C., Grooms P., Dusso A., Windus D. W., Slatopolsky E. Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. J Clin Invest. 1989 Apr;83(4):1349–1355. doi: 10.1172/JCI114022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dunlay R., Rodriguez M., Felsenfeld A. J., Llach F. Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int. 1989 Dec;36(6):1093–1098. doi: 10.1038/ki.1989.305. [DOI] [PubMed] [Google Scholar]
  7. Falchetti A., Bale A. E., Amorosi A., Bordi C., Cicchi P., Bandini S., Marx S. J., Brandi M. L. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab. 1993 Jan;76(1):139–144. doi: 10.1210/jcem.76.1.8421078. [DOI] [PubMed] [Google Scholar]
  8. Finch J. L., Rapp N., Martin K. J., Slatopolsky E. A new sensitive homologous radioimmunoassay for amino-terminal parathyroid hormone in the rat. J Bone Miner Res. 1992 Feb;7(2):229–233. doi: 10.1002/jbmr.5650070215. [DOI] [PubMed] [Google Scholar]
  9. Fukagawa M., Kaname S., Igarashi T., Ogata E., Kurokawa K. Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int. 1991 May;39(5):874–881. doi: 10.1038/ki.1991.110. [DOI] [PubMed] [Google Scholar]
  10. Heinrich G., Kronenberg H. M., Potts J. T., Jr, Habener J. F. Parathyroid hormone messenger ribonucleic acid: effects of calcium on cellular regulation in vitro. Endocrinology. 1983 Feb;112(2):449–458. doi: 10.1210/endo-112-2-449. [DOI] [PubMed] [Google Scholar]
  11. Hellman P., Akerström G., Ljunghall S., Rastad J. Surgical findings and results of subtotal and total parathyroidectomy in hypercalcemic patients with uremic hyperparathyroidism. Acta Chir Scand. 1989 Nov-Dec;155(11-12):573–582. [PubMed] [Google Scholar]
  12. Juhlin C., Rastad J., Klareskog L., Grimelius L., Akerström G. Parathyroid histology and cytology with monoclonal antibodies recognizing a calcium sensor of parathyroid cells. Am J Pathol. 1989 Aug;135(2):321–328. [PMC free article] [PubMed] [Google Scholar]
  13. Korkor A. B. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. N Engl J Med. 1987 Jun 18;316(25):1573–1577. doi: 10.1056/NEJM198706183162504. [DOI] [PubMed] [Google Scholar]
  14. Krause M. W., Hedinger C. E. Pathologic study of parathyroid glands in tertiary hyperparathyroidism. Hum Pathol. 1985 Aug;16(8):772–784. doi: 10.1016/s0046-8177(85)80248-3. [DOI] [PubMed] [Google Scholar]
  15. Kremer R., Bolivar I., Goltzman D., Hendy G. N. Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology. 1989 Aug;125(2):935–941. doi: 10.1210/endo-125-2-935. [DOI] [PubMed] [Google Scholar]
  16. Malmaeus J., Grimelius L., Johansson H., Akerström G., Ljunghall S. Parathyroid pathology in hyperparathyroidism secondary to chronic renal failure. Scand J Urol Nephrol. 1984;18(2):157–166. doi: 10.3109/00365598409182184. [DOI] [PubMed] [Google Scholar]
  17. Merke J., Hügel U., Zlotkowski A., Szabó A., Bommer J., Mall G., Ritz E. Diminished parathyroid 1,25(OH)2D3 receptors in experimental uremia. Kidney Int. 1987 Sep;32(3):350–353. doi: 10.1038/ki.1987.216. [DOI] [PubMed] [Google Scholar]
  18. Nygren P., Larsson R., Johansson H., Ljunghall S., Rastad J., Akerström G. 1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcif Tissue Int. 1988 Oct;43(4):213–218. doi: 10.1007/BF02555137. [DOI] [PubMed] [Google Scholar]
  19. Okazaki T., Igarashi T., Kronenberg H. M. 5'-flanking region of the parathyroid hormone gene mediates negative regulation by 1,25-(OH)2 vitamin D3. J Biol Chem. 1988 Feb 15;263(5):2203–2208. [PubMed] [Google Scholar]
  20. Pike J. W. Monoclonal antibodies to chick intestinal receptors for 1,25-dihydroxyvitamin D3. Interaction and effects of binding on receptor function. J Biol Chem. 1984 Jan 25;259(2):1167–1173. [PubMed] [Google Scholar]
  21. Russell J., Lettieri D., Sherwood L. M. Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene. Endocrinology. 1986 Dec;119(6):2864–2866. doi: 10.1210/endo-119-6-2864. [DOI] [PubMed] [Google Scholar]
  22. Shvil Y., Naveh-Many T., Barach P., Silver J. Regulation of parathyroid cell gene expression in experimental uremia. J Am Soc Nephrol. 1990 Jul;1(1):99–104. [PubMed] [Google Scholar]
  23. Silver J., Naveh-Many T., Mayer H., Schmelzer H. J., Popovtzer M. M. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest. 1986 Nov;78(5):1296–1301. doi: 10.1172/JCI112714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Silver J., Russell J., Sherwood L. M. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4270–4273. doi: 10.1073/pnas.82.12.4270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Slatopolsky E., Weerts C., Thielan J., Horst R., Harter H., Martin K. J. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest. 1984 Dec;74(6):2136–2143. doi: 10.1172/JCI111639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sone T., McDonnell D. P., O'Malley B. W., Pike J. W. Expression of human vitamin D receptor in Saccharomyces cerevisiae. Purification, properties, and generation of polyclonal antibodies. J Biol Chem. 1990 Dec 15;265(35):21997–22003. [PubMed] [Google Scholar]
  27. Szabo A., Merke J., Beier E., Mall G., Ritz E. 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int. 1989 Apr;35(4):1049–1056. doi: 10.1038/ki.1989.89. [DOI] [PubMed] [Google Scholar]
  28. Szabo A., Merke J., Thomasset M., Ritz E. No decrease of 1,25(OH)2D3 receptors and duodenal calbindin-D9k in uraemic rats. Eur J Clin Invest. 1991 Oct;21(5):521–526. doi: 10.1111/j.1365-2362.1991.tb01404.x. [DOI] [PubMed] [Google Scholar]
  29. Takagi H., Tominaga Y., Uchida K., Yamada N., Kano T., Kawahara K., Suzuki H. Polymorphism of parathyroid glands in patients with chronic renal failure and secondary hyperparathyroidism. Endocrinol Jpn. 1983 Aug;30(4):463–468. doi: 10.1507/endocrj1954.30.463. [DOI] [PubMed] [Google Scholar]
  30. Tominaga Y., Grimelius L., Falkmer U. G., Johansson H., Falkmer S. DNA ploidy pattern of parathyroid parenchymal cells in renal secondary hyperparathyroidism with relapse. Anal Cell Pathol. 1991 Nov;3(6):325–333. [PubMed] [Google Scholar]
  31. Tominaga Y., Takagi H., Suzuki H., Kondo T. [Histopathological study of the parathyroid gland in renal hyperparathyroidism]. Nihon Geka Gakkai Zasshi. 1985 May;86(5):630–639. [PubMed] [Google Scholar]
  32. Tominaga Y., Tanaka Y., Sato K., Numano M., Uchida K., Falkmer U., Grimelius L., Johansson H., Takagi H. Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg. 1992 Jul-Aug;16(4):595–603. doi: 10.1007/BF02067331. [DOI] [PubMed] [Google Scholar]
  33. Wallfelt C. H., Larsson R., Gylfe E., Ljunghall S., Rastad J., Akerström G. Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implication for parathyroid autotransplantation. World J Surg. 1988 Aug;12(4):431–438. doi: 10.1007/BF01655411. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES